Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1875 1
1966 1
1968 2
1969 1
1970 3
1971 4
1972 2
1973 9
1974 5
1975 8
1976 7
1977 9
1978 6
1979 13
1980 28
1981 10
1982 16
1983 18
1984 4
1985 12
1986 15
1987 10
1988 22
1989 15
1990 9
1991 13
1992 11
1993 10
1994 17
1995 14
1996 20
1997 15
1998 10
1999 13
2000 11
2001 8
2002 6
2003 10
2004 9
2005 7
2006 8
2007 6
2008 4
2009 5
2010 5
2011 6
2012 4
2013 8
2014 1
2015 3
2016 6
2017 4
2018 2
2019 3
2021 2
2022 1
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

463 results

Results by year

Filters applied: . Clear all
Page 1
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators. Torres VE, et al. N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121377 Free PMC article. Clinical Trial.
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC; Conference Participants. Chapman AB, et al. Kidney Int. 2015 Jul;88(1):17-27. doi: 10.1038/ki.2015.59. Epub 2015 Mar 18. Kidney Int. 2015. PMID: 25786098 Free PMC article.
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.
Rossetti S, Consugar MB, Chapman AB, Torres VE, Guay-Woodford LM, Grantham JJ, Bennett WM, Meyers CM, Walker DL, Bae K, Zhang QJ, Thompson PA, Miller JP, Harris PC; CRISP Consortium. Rossetti S, et al. Among authors: bennett wm. J Am Soc Nephrol. 2007 Jul;18(7):2143-60. doi: 10.1681/ASN.2006121387. Epub 2007 Jun 20. J Am Soc Nephrol. 2007. PMID: 17582161
Cyclosporine nephrotoxicity.
Burdmann EA, Andoh TF, Yu L, Bennett WM. Burdmann EA, et al. Among authors: bennett wm. Semin Nephrol. 2003 Sep;23(5):465-76. doi: 10.1016/s0270-9295(03)00090-1. Semin Nephrol. 2003. PMID: 13680536 Review.
Cyclosporine-associated hypertension.
Bennett WM, Porter GA. Bennett WM, et al. Am J Med. 1988 Aug;85(2):131-3. doi: 10.1016/s0002-9343(88)80330-9. Am J Med. 1988. PMID: 3400689 No abstract available.
Clinical nephrology.
Bennett WM, Grünfeld JP. Bennett WM, et al. Curr Opin Nephrol Hypertens. 1995 Mar;4(2):111-3. doi: 10.1097/00041552-199503000-00002. Curr Opin Nephrol Hypertens. 1995. PMID: 7600040 Review. No abstract available.
Immunosuppression: practice and trends.
Helderman JH, Bennett WM, Cibrik DM, Kaufman DB, Klein A, Takemoto SK. Helderman JH, et al. Among authors: bennett wm. Am J Transplant. 2003;3 Suppl 4:41-52. doi: 10.1034/j.1600-6143.3.s4.5.x. Am J Transplant. 2003. PMID: 12694049 Free article. Review. No abstract available.
Aminoglycoside nephrotoxicity.
Bennett WM. Bennett WM. Nephron. 1983;35(2):73-7. doi: 10.1159/000183050. Nephron. 1983. PMID: 6312345 Review. No abstract available.
Drug nephrotoxicity: an overview.
Bennett WM. Bennett WM. Ren Fail. 1997 Mar;19(2):221-4. doi: 10.3109/08860229709026280. Ren Fail. 1997. PMID: 9101595 Free article. Review.
463 results